Open AccessImpact of Peri-Transplant Rituximab and Host/Donor Fc Receptor Polymorphisms for Patients with Relapsed or Refractory CD20+ B-Cell Malignancies
Author(s) -
Noa Granot,
Andrew R. Rezvani,
Barry E. Storer,
Barbara S. Pender,
Brenda M. Sandmaier,
Rainer Storb,
David G. Maloney
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.466
Subject(s) - medicine , total body irradiation , rituximab , gastroenterology , cd20 , fludarabine , lymphoma , transplantation , immunology , oncology , chemotherapy , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom